Skip to main content
33°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RPRX
Recent news which mentions RPRX
< Previous
1
2
3
4
Next >
Top 5 Health Care Stocks That May Rocket Higher In Q1 2023
February 27, 2023
Tickers
ABT
AZTA
DCPH
GMED
Tags
health care stocks
Market News
Oversold Stocks
From
Benzinga
Preview: Royalty Pharma's Earnings
February 14, 2023
Tickers
RPRX
Tags
RPRX
Benzinga
Earnings
From
Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
Tickers
APLS
BIIB
CYTK
EBS
Tags
Small Cap
CYTK
Top Stories
From
Benzinga
Ominous Death Cross Forms On Royalty Pharma's Chart
January 10, 2023
Tickers
RPRX
Tags
Movers
Trading Ideas
Markets
From
Benzinga
6 Stocks Warren Buffett Completely Exited in 2022
December 17, 2022
Tickers
ABBV
BMY
BRK-A
BRK-B
Tags
STOR
BRK/B
Recent Press Releases
From
Motley Fool
Looking Into Royalty Pharma's Return On Capital Employed
December 06, 2022
Tickers
RPRX
Tags
RPRX
Benzinga
Earnings
From
Benzinga
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position
October 18, 2022
Tickers
DE
ERIE
RPRX
Tags
DE
RPRX
Recent Press Releases
From
Motley Fool
Jim Cramer Likes This Biotechnology Stock: 'It's Not Big, But It's Not Bad'
October 14, 2022
Tickers
AM
CTVA
DD
DFS
Tags
Jim Cramer
CTVA
ZTS
From
Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
September 19, 2022
Tickers
GSK
INVA
RPRX
TBPH
Tags
RPRX
Small Cap
News
From
Benzinga
Do Warren Buffett's Recent Moves Spell Doom for This Group of Stocks?
August 25, 2022
Tickers
ABBV
BMY
BRK-A
BRK-B
Tags
BRK/B
Recent Press Releases
RPRX
From
Motley Fool
Royalty Pharma's Return On Capital Employed Insights
August 22, 2022
Tickers
RPRX
Tags
BZI/ROCE
Market News
Benzinga
From
Benzinga
These Are the 6 Stocks Warren Buffett Sold in the Second Quarter
August 20, 2022
Tickers
BRK-A
BRK-B
GM
KR
Tags
KR
BRK/A
USB
From
Motley Fool
Buffett and Berkshire added big to their bets on Ally, Occidental, Paramount and Activision. But these other 6 stocks also got a vote of confidence.
August 16, 2022
Tickers
AAPL
ALLY
ATVI
BRK-B
Tags
CVX
MCK
MKL
From
MarketWatch
Warren Buffett's Berkshire Takes Another Bite Of Apple, Boosts Energy Holdings, Cashes Out Of Verizon: What 13F Filing Reveals
August 16, 2022
Tickers
AAPL
ALLY
AMZN
ATVI
Tags
BRKA
OXY
VZ
From
Benzinga
Jim Cramer Shares His Takes On First Solar, Royalty Pharma And More
August 11, 2022
Tickers
FSLR
LAC
RPRX
TSE
Tags
Trading Ideas
Markets
Benzinga
From
Benzinga
Expert Ratings for Royalty Pharma
August 08, 2022
Tickers
RPRX
Tags
Benzinga
Analyst Ratings
Market News
From
Benzinga
Royalty Pharma plc (RPRX) Q2 2022 Earnings Call Transcript
August 05, 2022
Tickers
RPRX
Tags
RPRX
Market News
Recent Press Releases
From
Motley Fool
Royalty Pharma: Q2 Earnings Insights
August 04, 2022
Tickers
RPRX
Tags
RPRX
BZI/Recaps
News
From
Benzinga
3 Things Most Investors Don't Know About Warren Buffett's Investing Style
August 04, 2022
Tickers
AAPL
DVA
JNJ
LLY
Tags
MCK
Market News
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Tickers
AMYT
BGNE
BLU
CFRX
Tags
BGNE
BLU
TBPH
From
Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
July 13, 2022
Tickers
GSK
INVA
RPRX
TBPH
Tags
Briefs
GSK
INVA
From
Benzinga
This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'
June 30, 2022
Tickers
BPMC
RPRX
Tags
General
Briefs
Health Care
From
Benzinga
Ipsen to acquire U.S.-based Epizyme for $247 million.
June 27, 2022
Tickers
EPZM
RPRX
Tags
RPRX
FR:IPN
EPZM
From
MarketWatch
5 Stocks Warren Buffett Has Aggressively Sold Since 2022 Began
June 17, 2022
Tickers
ABBV
BMY
BRK-A
BRK-B
Tags
BRK/A
VZ
Market News
From
Motley Fool
Expert Ratings for Royalty Pharma
June 14, 2022
Tickers
RPRX
Tags
RPRX
Analyst Ratings
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
June 14, 2022
Tickers
AERC
AINC
BBY
BGS
Tags
BZI/Ratings
HPE
KAMN
From
Benzinga
Management of Technology Companies Continue Selling - Zillow (Z)
May 31, 2022
Tickers
ANET
BODY
CAR
CB
Tags
Insider Trades
News
ANET
From
Benzinga
Royalty Pharma Earnings Perspective: Return On Capital Employed
May 27, 2022
Tickers
RPRX
Tags
Market News
BZI/ROCE
Benzinga
From
Benzinga
Executives Sell Around $325M Of 3 Stocks
May 24, 2022
Tickers
KD
PBF
RPRX
Tags
PBF
Insider Trades
News
From
Benzinga
Here's Every Stock Warren Buffett Bought or Sold in the First Quarter
May 17, 2022
Tickers
AAPL
ALLY
ATVI
BRK-A
Tags
ATVI
SYF
CE
From
Motley Fool
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.